We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Photoacoustic Imaging Could Monitor Prostate Cancer

By MedImaging International staff writers
Posted on 28 Jul 2016
Print article
Image: Cancer cells expressing PSMA (Photo courtesy Kent Nastiuk / RPCI).
Image: Cancer cells expressing PSMA (Photo courtesy Kent Nastiuk / RPCI).
A new study suggests that photoacoustic imaging (PAI) may be an effective tool for non-invasive monitoring of prostate cancer (PC).

Researchers at Roswell Park Cancer Institute (RPCI; Buffalo, NY, USA), the University of Rochester (NY, USA), and the Rochester Institute of Technology (RIT; NY, USA) conducted a study that focused laser light on phantoms containing PC cells, and then used ultrasound technology to see how molecular imaging agents that target the prostate-specific membrane antigen (PSMA) expressed under PAI. The two PSMA-targeting agents, ribonucleic acid aptamer (A10-3.2), and a urea-based peptidomimetic inhibitor (YC-27), were linked to the near-infrared (NIR) dye IRDye800CW.

The researchers found that the PAI with an acoustic lens enabled good discrimination between cells with and without the PSMA-targeting agent attached with both imaging agents. They found however, that YC-27 fluoresced much brighter and that conjugation of the modified chromophores was more tractable. They concluded therefore that the urea-targeting agent represents a better approach to developing “louder” signals necessary to overcome the challenges of detecting PC by PAI in vivo. The study was published in the June 2016 issue of the Journal of Biomedical Optics.

“This proof-of-concept study demonstrates that this technology may allow for real-time monitoring of prostate cancer in patients during the course of active surveillance. For patients with more aggressive disease, the technology could offer more precise targeting of biopsies to confirm the need for definitive therapy,” said senior author Kent Nastiuk, PhD, assistant professor of cancer genetics and genitourinary cancers at RPCI. “This technology offers the potential to confirm the initial prostate cancer diagnosis, guide biopsies and monitor tumor volume — which is currently not measureable — for improved case management and treatment decision-making.”

PAI uses non-ionizing laser pulses delivered into biological tissues. Some of the delivered energy is absorbed and converted into heat, leading to transient thermoelastic expansion, and thus wideband ultrasonic emission, which can be detected by ultrasonic transducers and analyzed to produce images. The magnitude of the photoacoustic signal is proportional to the local energy deposition, which can be demonstrated by optical absorption contrast on the images of the targeted areas.

Related Links:
Roswell Park Cancer Institute
University of Rochester
Rochester Institute of Technology
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
DR Flat Panel Detector
1500L
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The CIARTIC Move self-driving mobile C-arm has received FDA clearance (Photo courtesy of Siemens)

Self-Driving Mobile C-Arm Reduces Imaging Time during Surgery

Intraoperative imaging faces significant challenges due to staff shortages and the high demands placed on surgical teams in the operating room (OR). A common challenge during many OR procedures is the... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.